 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || LNK01004 / Lynk Pharmaceuticals
New P1 trial: Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis. (clinicaltrials.gov) - Aug 14, 2024
P1, N=28, Completed, Sponsor: Lynk Pharmaceuticals Co., Ltd